Introduction

Novocrine Oxasim is marketed as containing 10 mg/tablet of oxandrolone and is presented in a 100-tablet bottle. To validate its label claims and ensure product transparency, AnabolicLab procured samples of Oxasim and submitted them for independent laboratory analysis.

The analysis, conducted by SIMEC AG, revealed that Oxasim significantly exceeded its label claim, delivering 14.7 mg/tablet of oxandrolone—147% of the declared dosage. However, it was later clarified by Novocrine that the vendor misrepresented itself as an authorized reseller. Novocrine stated that it does not permit online sales of its products and does not have authorized European-based distributors. This correction highlights the importance of verifying sources when purchasing products. The analysis and sample submission were funded by AnabolicLab as part of its commitment to transparency and harm reduction in the anabolic steroid market.

Product Overview

• Manufacturer: Novocrine
• Product Name: Oxasim
• Active Ingredient: Oxandrolone
• Batch Number: 512214
• Delivery Method: Oral tablets (100 tablets, 10 mg each)
• Specification: 10 mg/tablet oxandrolone (as per label claim)

Sample Acquisition and Testing

• Date Purchased: Between June 1, 2015, and June 30, 2015
• Source: Internet-based reseller (later determined to be unauthorized)
• Product Submitted By: AnabolicLab
• Analysis Paid For By: AnabolicLab
• Analysis Performed By: SIMEC AG
• Date Received by Lab: July 10, 2015
• Date Report Completed: July 23, 2015

Testing Results

1. Quantitative Dosage Testing (HPLC-UV):
   • Claimed Dosage: 10 mg/tablet
   • Measured Dosage: 14.7 mg/tablet oxandrolone
   • Accuracy: 147% (significantly exceeds label claim)
2. Correction:
   • On February 4, 2016, Novocrine clarified that the vendor who sold the product was not an authorized reseller. Novocrine explicitly prohibits online sales of its products and does not have an authorized European-based distributor.

Summary

Novocrine Oxasim was determined to significantly exceed its labeled dosage specification, delivering 14.7 mg/tablet oxandrolone compared to the declared 10 mg/tablet. However, Novocrine later clarified that the vendor misrepresented itself as an authorized reseller. This highlights the importance of verifying sources when purchasing products. By funding the analysis and submitting the samples, AnabolicLab reinforces its dedication to transparency and harm reduction in the anabolic steroid market.

Disclaimer: The information provided here is for educational and harm reduction purposes only. AnabolicLab does not endorse or promote the use of anabolic steroids or other controlled substances.

(The following images are photographs of the actual product that was submitted for testing.)

Novocrine Oxasim Oral Dosage Quantification Lab Results [PDF]
How many milligrams of oxandrolone (aka Anavar) does each tablet of Novocrine Oxasim contain? HPLC-UV (July 23, 2015) …

Size	128.82 KB
Downloaded	5578 times
Last Updated	February 6, 2016
Download

---

Oxandrolone Raw Data HPLC-UV [PDF]
This PDF report (20 MB) includes the HPLC-UV raw data from lab testing reports completed by SIMEC on July 23, 2015 on the following oxandrolone (Anavar) products: C34027 – Excel Pharma Athenavar, C34028…

Size	19.52 MB
Downloaded	3118 times
Last Updated	February 7, 2016
Download

---